tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Medicenna to Present Innovative Cancer Data at Conferences

Story Highlights
Medicenna to Present Innovative Cancer Data at Conferences

Medicenna Therapeutics Corp (TSE:MDNA) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Medicenna Therapeutics Corp. is set to present promising pre-clinical data on its innovative IL-2 Superkines, MDNA11, at two major oncology conferences. These presentations could attract investor interest as they highlight advancements in treating aggressive cancers like glioblastoma and breast cancer.

For further insights into TSE:MDNA stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1